Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Histone citrullination in estrogen receptor signaling and breast cancer

ABSTRACT: Histone citrullination in estrogen receptor signaling and breast cancer

PROVIDER: PRJNA704669 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13779100_1.fastq.gz	Fastqsanger.gz
	SRR13779100_2.fastq.gz	Fastqsanger.gz
	SRR13779200_1.fastq.gz	Fastqsanger.gz
	SRR13779200_2.fastq.gz	Fastqsanger.gz
	SRR13779101_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 272

Similar Datasets

Histone citrullination in estrogen receptor signaling and breast cancer [PRO-seq]

Project description:Histone citrullination in estrogen receptor signaling and breast cancer [PRO-seq]

| PRJNA704674 | ENA

Histone citrullination in estrogen receptor signaling and breast cancer [ChIP-seq]

Project description:Histone citrullination in estrogen receptor signaling and breast cancer [ChIP-seq]

| PRJNA704673 | ENA

Histone citrullination in estrogen receptor signaling and breast cancer [PRO-seq]

Project description:PAD2, one of a family of PAD enzymes that convert positively charged arginine residues on target proteins to neutrally charged citrulline, has been shown to play a role in estrogen signaling through interactions with histone H3R26. The objectives of this project are to define the role of PAD2 in estrogen receptor alpha signaling, tumor progression, and tamoxifen resistance.

2022-01-15 | GSE167452 | GEO

Histone citrullination in estrogen receptor signaling and breast cancer [ChIP-seq]

2022-01-15 | GSE167451 | GEO

Histone citrullination in estrogen receptor signaling and breast cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-01-15 | GSE167453 | GEO

PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription

Project description:HIV-1 infection establishes a reservoir of long-lived cells with integrated proviral DNA that can persist despite antiretroviral therapy (ART). The mechanisms governing the transcriptional regulation of the provirus are complex and incompletely understood. Here, we investigated the role of histone H3 citrullination, a post-translational modification catalyzed by protein-arginine deiminase type-4 (PADI4), in HIV-1 transcription and latency. We found that PADI4 inhibition by GSK484 reduced HIV-1 transcription after T cell activation in ex vivo cultures of CD4 T cells from viremic and ART treated people living with HIV-1 (PLWH). The effect was more pronounced in the viremic group. Using cell models of HIV-1 latency, we showed that PADI4-mediated citrullination of histone H3 occurred at the HIV-1 promoter upon T cell stimulation which facilitated proviral transcription. HIV-1 preferentially integrated into genomic regions marked by H3 citrullination and these integrated proviruses were less prone to latency compared to those in non-citrullinated chromatin. Inhibiting PADI4 led to compaction of the HIV-1 promoter chromatin and an increase of HP1a-covered heterochromatin, in a mechanism partly dependent on the HUSH complex. Our data reveal a novel mechanism of HIV-1 transcriptional regulation by PADI4 through H3 citrullination.

2024-08-05 | GSE273899 | GEO

Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples

Project description:Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples Keywords: breast cancer type comparison

2008-09-17 | GSE10510 | GEO

Estrogen Receptor alpha and Histone Lysine Methyltransferase DOT1L chromatin bound interactome

Project description:Estrogen Receptor alpha (ERα) is a ligand-inducible transcription factor that mediates estrogen signaling in hormone-responsive breast cancer (BC) and is the primary target of specific anticancer therapies. Although ERα blockade with these drugs is effective, the development of a resistance to treatment represents the key problem in clinical management of patients affected by this disease. Understanding the molecular mechanisms underlying ERα action in BC cells may help the identification of new therapeutic targets for more effective pharmacological treatment of endocrine therapy-resistant tumors. We recently discovered the epigenetic enzyme DOT1L (DOT1 Like Histone Lysine Methyltransferase) as a novel nuclear partner of ERα in BC cells. To investigate the involvement of DOT1L in mediating ERα actions in hormone-responsive and endocrine-resistant BC, physical and functional interaction between these two molecules on chromatin was mapped by Chromatin Immunoprecipitation coupled to Mass Spectrometry (ChIP-MS).

2019-02-09 | PXD010314 | Pride

Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples

Project description:Comparison between Estrogen receptor positive and Estrogen receptor negative breast cancer samples Keywords: breast cancer type comparison 152 unique breast cancer tissue sample are included in the analysis. The total mRNA has been labeled with Cy5 and then hybridized on a two color arrays against the stratagen Human common reference that was previously labelled with Cy3.

2008-09-17 | E-GEOD-10510 | biostudies-arrayexpress

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

Project description:Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

| PRJNA815854 | ENA